SCHEMBL6566936

SCHEMBL6566936

O=S(=O)(Cc1ccccc1)Nc1ccccc1O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.56
CA2 P00918 1/20 0.56
MMP1 P03956 1/20 0.56
MMP2 P08253 1/20 0.56
MMP9 P14780 1/20 0.56
MMP8 P22894 1/20 0.56
MMP13 P45452 1/20 0.56
GLO1 Q04760 1/20 0.54
PGAM1 P18669 1/20 0.53
ACLY P53396 1/20 0.52
KMT2A Q03164 2/20 0.51
PTGES2 Q9H7Z7 2/20 0.51
PARP14 Q460N5 1/20 0.51
HPGD P15428 2/20 0.50
MAPK1 P28482 2/20 0.50
MEN1 O00255 1/20 0.50
GAA P10253 1/20 0.50
MAPT P10636 1/20 0.50
HTT P42858 1/20 0.50
RECQL P46063 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4357558 0.83 ACLY (0.51) CA1CA2MMP1MMP2MMP9
SCHEMBL4347808 0.81 ALDH1A1 (0.56) CA1CA2MMP1MMP2MMP9
SCHEMBL6567611 0.81 PTGES2 (0.55) CA1CA2MMP1MMP2MMP9
SCHEMBL11640095 0.80 EP300 (0.59) CA1CA2MMP1MMP2MMP9
SCHEMBL6137932 0.79 ACLY (0.69) CA1CA2MMP1MMP2MMP9
SCHEMBL4351613 0.79 KMT2A (0.53) CA1CA2MMP1MMP2MMP9
SCHEMBL4357672 0.79 GLO1 (0.51) CA1CA2MMP1MMP2MMP9
SCHEMBL7898382 0.79 GLO1 (0.54) CA1CA2MMP1MMP2MMP9
SCHEMBL14403271 0.79 ALDH1A1 (0.55) CA1CA2MMP1MMP2MMP9
SCHEMBL14873529 0.78 CA1 (0.51) CA1CA2MMP1MMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1402887-A1 New compounds for the inhibition of undesired cell proliferation and use thereof Jerini AG (DE) 2004-03-31 EP claimed
EP-1402888-A1 The use of substituted carbocyclic compounds as rotamases inhibitors Jerini AG (DE) 2004-03-31 EP claimed
US-5112820-A Vision defects STERLING DRUG INC. (US) 1992-05-12 US disclosed
US-5109135-A 2- or 3-aminomethyl-4-amino-3,4-dihydro-2H-1,4-benzoxazine intermediates STERLING DRUG INC. (US) 1992-04-28 US disclosed
US-5066803-A Chemical intermediates for analgesics STERLING DRUG INC. (US) 1991-11-19 US disclosed
WO-1990007505-A1 2- AND 3-AMINOMETHYL-6-ARYLCARBONYL-2,3-DIHYDROPYRROLO[1,2,3-de]-1,4-BENZOXAZINES STERLING DRUG INC. (US) 1990-07-12 WO disclosed
US-4939138-A 2- and 3-aminomethyl-6-arylcarbonyl-2,3-dihydropyrrolo(1,2,3-DE)-1,4-benzoxazines STERLING DRUG INC. (US) 1990-07-03 US disclosed